Full Text
Evaluation of The Cost Effectiveness of Rifaximin-á 550mg In The Reduction of Recurrence of Overt Hepatic Encephalopathy In Sweden

Abstract

Authors

CD Poole E Berni P Conway A Radwan CJ Currie

Back to Volume 18, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×